Riskpilot← Back to searchSign inGet full accessHem & Hälsa i Väst AB
ABActiveOrg 5591371553Rental and operating of own or leased real estate · NACE 6820Est. 20170 employees
Revenue 2024
SEK 904K
+62% vs 2023
EBITDA margin
67.5%
+56% vs 2023
Equity ratio
1.6%
Financial strength
Net profit 2024
SEK -17K
-117% vs 2023
| Revenue | SEK 904K | +62% |
| EBITDA | SEK 610K | +56% |
| Net profit | SEK -17K | -117% |
| Total assets | SEK 7M | +19% |
| Equity | SEK 111K | -13% |
| Employees | 0 | — |
Legal name
Hem & Hälsa i Väst AB
Org number
5591371553
Legal form
Aktiebolag
NACE code
6820 · Rental and operating of own or leased real estate
Founded
4 december 2017
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att bedriva förvaltning av fastigheter, kapital och värdepapper och därmed förenlig verksamhet.
Address
Email
lintonbostader@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 620 | 739 | 298 | 557 | 904 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 462 | 573 | 187 | 391 | 610 |
| Depreciation & amort. | −127 | −127 | −63 | −127 | −191 |
| EBIT | 335 | 446 | 124 | 264 | 420 |
| Net financials | −97 | 1 870 | 982 | −137 | −435 |
| Profit before tax | 179 | 2 316 | 1 225 | 127 | −15 |
| Tax | −39 | −77 | −42 | −27 | −2 |
| Net profit | 140 | 2 239 | 1 183 | 100 | −17 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 566 | 7 017 | 6 092 | 5 860 | 6 988 |
| Equity | 308 | 2 548 | 1 233 | 128 | 111 |
| Long-term debt | 7 649 | 3 843 | 4 260 | 5 523 | 6 619 |
| Short-term debt | 490 | 508 | 599 | 208 | 257 |
| Total debt | 8 139 | 4 351 | 4 859 | 5 732 | 6 877 |
EBITDA margin
67.5%
This company
15.8%
Market median
+327% vs market
20202024
Equity ratio
1.6%
This company
38.2%
Market median
-96% vs market
20202024
Return on equity
-15.3%
This company
18.4%
Market median
-183% vs market
20202024
Net profit margin
-1.9%
This company
8.1%
Market median
-123% vs market
20202024
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20202024
Debt / equity
61.89×
This company
0.62×
Market median
-9882% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AO Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
JÅ Chief Executive Officer | Chief Executive Officer | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2022 | |
| Chairman | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Linton Bostäder AB
Hem & Hälsa i Väst AB Board members of Hem & Hälsa i Väst AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Åke Marcus Parmlid | Chief Executive Officer | 0 companies |
| Anton Olof Svensson | Chief Executive Officer | 0 companies |
| Åke Lennart Parmlid | Deputy Board Member | 0 companies |
| Linus Thomas Svensson | Deputy Board Member | 0 companies |
| Fredrik Gunnar Parmlid | Chairman | 0 companies |